| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 7.887 | 31.671 | 63.302 | 71.683 | 66.732 | 56.204 | 54.932 |
| Total Income - EUR | - | - | - | 7.887 | 31.671 | 63.302 | 71.735 | 67.037 | 58.837 | 56.437 |
| Total Expenses - EUR | - | - | - | 4.918 | 10.544 | 12.561 | 18.944 | 18.651 | 27.744 | 27.632 |
| Gross Profit/Loss - EUR | - | - | - | 2.968 | 21.127 | 50.741 | 52.791 | 48.386 | 31.093 | 28.806 |
| Net Profit/Loss - EUR | - | - | - | 2.732 | 20.177 | 49.334 | 51.810 | 47.387 | 30.505 | 27.113 |
| Employees | - | - | - | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Cons Anco Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 19.559 | 14.615 | 11.575 | 7.565 | 3.804 |
| Current Assets | - | - | - | 2.966 | 20.737 | 48.199 | 53.542 | 77.398 | 53.359 | 49.468 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 14 | 2.412 | 47.143 | 44.492 | 47.107 |
| Cash | - | - | - | 2.966 | 20.737 | 48.185 | 51.130 | 30.255 | 8.867 | 2.361 |
| Shareholders Funds | - | - | - | 2.775 | 20.227 | 49.383 | 52.054 | 47.435 | 30.553 | 27.161 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 192 | 510 | 18.375 | 16.103 | 41.537 | 30.371 | 26.111 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cons Anco Med S.r.l.